73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Tackling tumour scar tissue could be key to treating pancreatic cancer

Tackling tumour scar tissue could be key to treating pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainThe first study in the world to take a detailed look

Tackling tumour scar tissue could be key to treating pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainThe first study in the world to take a detailed look
Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030
Newly discovered mechanism helps tumor cells evade the immune system early on

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache
New chemical weapon to combat cancer

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers
Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

by Jay Furst,Mayo ClinicCredit: AI-generated imageMore than half of all patients who receive solid organ transplants will have an incidence of skin cancer at some point—most often a nonmelanoma

Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

by Jay Furst,Mayo ClinicCredit: AI-generated imageMore than half of all patients who receive solid organ transplants will have an incidence of skin cancer at some point—most often a nonmelanoma
Research perspective: Cancer prevention with rapamycin

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t
Blood cancers: Expert explains what you need to know

Blood cancers: Expert explains what you need to know

by Robin FosterBlood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.First, bloo

Blood cancers: Expert explains what you need to know

by Robin FosterBlood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.First, bloo
Overall cancer mortality continues to decline

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl
Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi
New computer platform helps match patients with cancer to trials of targeted therapy

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are
Team identifies key driver of cancer cell death pathway that activates immune cells

Team identifies key driver of cancer cell death pathway that activates immune cells

by University of Illinois at Urbana-ChampaignThe research team included, from left, research scientist Chengjian Mao, graduate student Xinyi Dai, biochemistry professor David Shapiro, graduate st

Team identifies key driver of cancer cell death pathway that activates immune cells

by University of Illinois at Urbana-ChampaignThe research team included, from left, research scientist Chengjian Mao, graduate student Xinyi Dai, biochemistry professor David Shapiro, graduate st
Cancer risk found to be higher in asthma patients

Cancer risk found to be higher in asthma patients

by Lori SolomonPeople with asthma are more likely to develop cancer, particularly those not using inhaled steroids, according to a study published online March 31 inCancer Medicine.Yi Guo, Ph.D.

Cancer risk found to be higher in asthma patients

by Lori SolomonPeople with asthma are more likely to develop cancer, particularly those not using inhaled steroids, according to a study published online March 31 inCancer Medicine.Yi Guo, Ph.D.